This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ, other sites/unspecified
CD2_INSITU_MELANOMA_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Melanoma in situ, other sites/unspecified
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ, other sites/unspecified
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 102 | 52 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 66.86 | 63.36 | 70.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 931
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
98.0
76
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
31.0
29.0
39
21
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
79.6
22.1
24
*
D03.8
ICD-10 Finland
Melanoma in situ of other sites
+∞
20.6
19
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
24.8
19.2
27
15
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.1
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
176.6
14.9
15
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
176.6
14.9
15
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
13.9
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.9
13
*
L57.0
ICD-10 Finland
Actinic keratosis
9.8
13.3
28
39
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
13.8
11.7
20
18
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.7
11
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.4
11.0
25
39
D03.5
ICD-10 Finland
Melanoma in situ of trunk
+∞
10.6
10
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.2
10.4
30
66
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
23.2
10.2
14
7
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
13.6
10.1
17
15
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.5
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.5
9
*
TQW99
NOMESCO Finland
Other minor procedure on skin
11.8
8.9
16
16
A04AA02
ATC
granisetron; systemic, transdermal
+∞
8.5
8
*
130
Kela drug reimbursment
Malignant tumour
+∞
8.5
8
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
86.7
7.5
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
7.4
7
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
7.4
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
7.4
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.4
7
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
7.4
7
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
8.2
7.4
16
23
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
43.3
6.9
8
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
24.6
6.8
9
*
S18
ICPC
Laceration/cut
3.2
6.5
53
275
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
+∞
6.3
6
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
S77
ICPC
Malignant neoplasm of skin
+∞
6.3
6
*
SPAT1153
SPAT
Removal of sutures
3.2
6.3
45
212
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
16.4
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
48
59
14.48
39.96
1.8
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
83
241
14.12
33.27
4.7
1.5
—
—
—
0
0
(4035726)
28
23
16.40
29.37
1.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
17
6.41
5.74
1.0
2.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
0
+∞
5.25
1.0
0.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
49
269
2.58
5.20
3.7
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
38
186
2.66
5.07
2.6
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
45
244
2.51
4.82
3.0
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
5
14.88
4.64
1.1
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
349
2.44
4.64
4.5
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
58
361
2.41
4.51
5.9
5.0
mmol/l
1.2
1.2
0.52
52
324
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
399
2.32
4.10
7.0
5.1
mmol/l
1.2
1.2
1.12
47
340
(3015377) Calcium [Moles/volume] in Serum or Plasma
43
250
2.24
3.75
3.3
2.1
mmol/l
2.4
2.3
0.17
37
212
(3013650) Neutrophils [#/volume] in Blood by Automated count
64
438
2.24
3.72
9.5
5.8
e9/l
3.9
4.5
1.32
55
381
(3009261) Glucose [Presence] in Urine by Test strip
59
398
2.14
3.47
3.4
3.7
estimate
0.0
0.0
0.00
16
58
(3035350) Ketones [Presence] in Urine by Test strip
58
389
2.14
3.46
3.4
3.7
estimate
0.0
0.0
0.00
15
62
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
80
611
2.43
3.43
5.2
4.0
pmol/l
14.9
15.0
0.18
71
548
(3000850) Epithelial cells [#/volume] in Urine
30
156
2.31
3.36
2.8
2.5
e6/l
10.7
4.9
0.58
25
131
(3021601) Nitrite [Presence] in Urine by Test strip
58
393
2.10
3.32
4.2
5.1
estimate
0.0
0.0
0.00
16
63
(3007853) Bacteria identified in Skin by Aerobe culture
22
102
2.48
3.15
1.9
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
80
623
2.32
3.09
9.4
5.0
u/l
74.0
77.5
0.61
74
575
(40760892) CBC W Ordered Manual Differential panel - Blood
31
170
2.18
3.03
5.1
4.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
58
2.86
3.03
3.7
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
34
201
2.04
2.71
4.1
4.2
estimate
0.0
0.0
0.00
15
61
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
15
4.92
2.64
1.7
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
76
2.48
2.61
4.6
3.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
53
2.67
2.39
5.8
4.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
72
566
1.93
2.33
5.5
3.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
74
2.38
2.29
1.1
1.3
—
—
—
0
0
(3013512) EKG study
41
273
1.84
2.25
4.4
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
38
251
1.82
2.12
3.4
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
43
295
1.79
2.11
3.9
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
33
209
1.86
2.10
3.8
3.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
378
1.77
2.10
3.8
3.9
ng/l
32.6
54.4
0.96
35
275
(3015736) pH of Urine
44
305
1.78
2.08
3.1
3.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
55
407
1.76
2.08
7.0
5.1
e9/l
0.2
0.2
1.93
47
354
(3002582) Erythrocytes [#/volume] in Urine
37
244
1.81
2.06
4.0
2.8
e6/l
16.4
332.0
0.59
31
178
(3004588) Protein electrophoresis panel - Serum or Plasma
14
64
2.38
2.05
1.1
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
32
202
1.85
2.05
2.8
2.1
mg/l
3.4
2.8
0.87
27
171
(3000494) Fungus identified in Specimen by Culture
18
93
2.14
2.00
1.1
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
16
79
2.22
1.98
3.6
1.7
nmol/l
548.1
399.4
0.37
16
71
(3001604) Monocytes [#/volume] in Blood
53
393
1.73
1.95
6.7
5.1
e9/l
0.6
0.6
0.05
45
339
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
92
808
2.41
1.94
21.9
13.0
mg/l
22.3
24.4
0.30
82
635
(3006315) Basophils [#/volume] in Blood
53
394
1.72
1.93
6.7
5.1
e9/l
0.0
0.0
0.66
45
343
(3009508) Creatinine [Moles/volume] in Urine
40
275
1.75
1.92
3.4
2.9
mmol/l
7.3
7.5
0.09
31
232
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
35
2.72
1.85
2.0
2.1
ug/l
229.3
1785.8
—
9
30
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
12
4.32
1.84
1.0
1.2
pmol/l
104.0
56.0
—
5
12
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
13
61
2.30
1.80
5.7
3.4
kpa
5.1
5.1
0.03
13
54
(3019198) Lymphocytes [#/volume] in Blood
53
400
1.68
1.78
6.7
5.2
e9/l
1.8
1.9
0.49
47
353
(3018095) Leukocytes [#/volume] in Urine
40
280
1.71
1.78
4.3
3.5
e6/l
84.4
65.5
0.18
33
195
(3032080) INR in Blood by Coagulation assay
47
344
1.68
1.77
13.8
8.3
inr
1.2
1.3
0.10
16
95
(3030467) Casts [#/volume] in Urine by Automated count
33
219
1.75
1.77
3.9
2.7
e6/l
2.0
0.6
0.33
27
152
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
88
767
2.07
1.77
21.2
12.1
ml/min/173m2
75.7
75.0
0.09
79
622
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
86
745
1.98
1.74
6.3
4.8
mu/l
2.1
1.9
0.29
77
676
(3020564) Creatinine [Moles/volume] in Serum or Plasma
95
860
2.52
1.73
23.9
15.2
umol/l
88.1
82.3
0.36
95
860
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
291
1.68
1.72
2.7
3.0
ng/l
2242.7
1241.9
0.48
36
246
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
89
781
2.10
1.72
4.9
4.4
mmol/l
1.3
1.3
0.35
82
717
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
93
1.99
1.63
1.5
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
17
94
1.97
1.59
2.8
2.2
%
1.9
1.6
0.44
17
84
(3026493) Urate [Moles/volume] in Serum or Plasma
33
226
1.68
1.56
3.9
2.4
umol/l
347.1
9820.0
1.54
27
191
(3017181) Myelocytes/100 leukocytes in Blood
12
58
2.21
1.56
4.8
3.8
%
0.6
0.9
—
5
16
(3001122) Ferritin [Mass/volume] in Serum or Plasma
43
317
1.62
1.53
4.0
2.7
ug/l
200.6
122.7
0.87
38
291
(36304419) Bacteria [Presence] in Urine
31
210
1.68
1.53
3.9
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
37
2.57
1.52
2.2
1.8
g/l
1.4
1.7
—
9
32
(3012516) Albumin [Mass/volume] in Urine
38
272
1.63
1.52
3.5
3.0
mg/l
43.4
295.9
0.54
27
174
(3045414) Leukocytes [Presence] in Urine
9
39
2.43
1.47
2.3
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
39
2.43
1.47
1.7
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
40
292
1.61
1.47
4.9
3.8
mg/mmol
11.5
8.6
0.14
26
188
(3019225) pH of Specimen
15
82
1.97
1.45
6.4
3.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
40
2.37
1.44
6.8
3.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
17
98
1.88
1.41
3.2
4.9
mmol/l
105.4
103.6
0.53
17
93
(3018418) pH of Serum or Plasma
33
233
1.62
1.37
5.7
3.2
ph
7.4
7.4
0.07
11
38
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
17
3.04
1.37
2.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
92
836
2.02
1.30
22.3
12.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
18
2.87
1.30
1.4
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
90
816
1.88
1.22
5.5
4.9
mmol/l
4.5
4.5
0.02
83
761
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
52
418
1.50
1.19
2.0
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
26
179
1.61
1.19
1.7
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
90
819
1.84
1.16
5.8
4.8
mmol/l
6.4
6.0
0.77
81
748
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
89
809
1.79
1.13
5.5
4.8
mmol/l
1.5
1.5
0.02
82
749
(3049717) Cytology report of Urine Cyto stain
5
21
2.45
1.10
2.8
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
21
2.45
1.10
1.6
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
81
721
1.60
1.09
19.1
13.6
%
37.8
39.6
0.75
48
483
(3006504) Eosinophils/100 leukocytes in Blood
46
367
1.46
1.06
7.7
5.1
%
2.5
2.9
0.83
40
341
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
41
320
1.47
1.06
5.8
3.9
ug/l
2.6
2.0
0.56
35
293
(3019069) Monocytes/100 leukocytes in Blood
46
368
1.46
1.04
8.3
5.5
%
9.0
8.5
0.29
40
343
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
185
1.54
1.03
2.4
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
35
2.07
1.02
1.4
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
9
50
1.88
0.99
1.9
6.5
%
0.9
0.7
—
9
50
(3008898) HLA-B27 [Presence]
0
28
0.00
0.99
0.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
42
333
1.44
0.99
15.6
8.4
e9/l
0.0
0.0
0.49
33
256
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
9
51
1.84
0.97
1.9
6.4
%
1.7
1.6
—
9
51
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
51
1.84
0.97
2.4
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
46
375
1.41
0.92
8.0
5.3
%
27.2
26.7
0.10
40
348
(3021960) Folate [Moles/volume] in Serum or Plasma
29
217
1.47
0.91
1.5
1.5
nmol/l
23.7
20.5
0.26
21
189
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
90
834
1.67
0.87
5.9
5.4
mmol/l
2.6
2.6
0.02
83
773
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
66
581
1.39
0.80
5.2
3.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
43
354
1.37
0.79
8.0
5.0
%
0.6
0.7
0.23
38
328
(3020891) Body temperature
6
34
1.81
0.77
1.5
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
40
1.80
0.73
1.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
102
1.55
0.72
8.1
8.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
26
199
1.41
0.72
1.6
1.8
pmol/l
393.3
460.0
0.78
20
163
(3042936) Bacteria identified in Isolate by Culture
17
120
1.50
0.70
1.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
13
86
1.59
0.70
1.6
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
44
370
1.33
0.68
7.9
5.1
%
56.0
58.1
0.40
38
346
(3023368) Bacteria identified in Blood by Culture
27
210
1.39
0.68
8.5
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
28
1.82
0.67
4.6
3.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
175
1.41
0.66
4.7
2.6
ug/l
1.0
0.7
0.51
14
120
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
13
88
1.55
0.64
1.6
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
13
88
1.55
0.64
1.8
2.1
umol/l
11.1
6.8
0.30
13
74
(42870588) Differential panel, method unspecified - Blood
32
260
1.34
0.62
7.9
4.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
125
1.43
0.58
1.6
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
244
1.33
0.57
5.4
3.6
%
22.1
24.8
0.53
16
119
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
38
1.61
0.55
1.2
1.1
g/l
9.9
10.4
—
6
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
83
777
1.37
0.54
7.4
6.7
mmol/mol
42.5
40.9
0.63
74
726
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
63
1.47
0.54
1.8
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
40
1.53
0.52
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
69
1.50
0.46
2.3
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
41
358
1.24
0.44
2.4
1.9
pmol/l
98.5
96.7
0.06
21
184
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
31
1.64
0.43
1.0
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
33
1.54
0.42
1.0
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
123.8
—
0
6
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
16
0.00
0.41
0.0
6.7
—
106.1
—
0
16
(3039000) Anion gap in Blood
0
16
0.00
0.41
0.0
6.7
—
11.1
—
0
16
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
111
0.70
0.40
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
22
181
1.27
0.39
2.4
1.8
nmol/l
1191.2
1139.3
0.09
13
138
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
36
1.41
0.39
1.0
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
36
1.41
0.39
1.2
1.1
g/l
35.8
37.3
—
5
29
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
36
1.41
0.39
1.0
1.1
g/l
0.0
0.4
—
5
31
(1761868) Lipid panel - Serum or Plasma
34
295
1.23
0.38
3.3
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
58
532
1.21
0.38
2.8
3.0
u/l
51.4
51.7
0.01
51
493
(40768797) Stomach Pathology biopsy report
16
128
1.30
0.34
1.4
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
7
51
1.40
0.32
1.4
2.4
g/l
8.6
11.6
—
7
43
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
76
1.35
0.29
1.9
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
68
642
1.18
0.28
25.9
15.5
%
14.0
13.7
1.02
63
625
(40758558) Short blood count panel - Blood
21
180
1.21
0.26
6.1
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
134
1.23
0.24
4.0
2.5
e6/l
1.1
2.4
—
10
65
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
26
230
1.18
0.24
1.6
1.6
mmol/l
1.2
1.4
0.63
17
197
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.23
1.2
1.1
g/l
3.6
3.2
—
5
32
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
339.0
—
0
11
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
13
0.00
0.21
0.0
2.2
—
552.3
—
0
8
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
59
1.20
0.18
1.3
4.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
7
61
1.16
0.18
1.9
7.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
139
1.18
0.17
1.1
1.3
u/ml
1.5
20.0
—
7
57
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
78
1.17
0.16
2.7
3.1
ng/l
142.4
224.7
—
9
70
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
93
1.20
0.15
1.5
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
36
340
1.09
0.11
2.5
2.2
nmol/l
88.3
77.8
1.12
28
301
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
11
96
1.16
0.11
1.9
5.6
kpa
5.3
5.2
0.12
11
91
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
43
1.17
0.10
2.6
6.3
mmol/l
24.6
25.5
—
5
37
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
46
1.09
0.10
2.0
2.2
%
0.9
1.2
—
5
46
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
56
1.08
0.09
2.8
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
58
1.04
0.08
3.3
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
63
1.12
0.08
1.7
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
147
1.02
0.00
3.9
2.3
e6/l
0.5
0.9
—
9
77
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
15
151
0.99
0.00
1.2
1.2
u/ml
0.6
1.2
—
5
45
(3012544) pH of Venous blood
9
96
0.93
0.00
2.2
3.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
5.2
5.5
mmol/l
24.7
24.9
—
5
51
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4306422)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
58
0.86
0.00
1.2
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
50
1.00
0.00
1.8
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
28.6
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
1.0
—
0
9
(4010399)
6
68
0.88
0.00
1.5
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
10.5
—
0
7
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
12.6
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
3.7
—
13.3
—
0
6
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
6
59
1.02
0.00
1.8
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
6
0.00
0.00
0.0
2.0
—
2791.7
—
0
6
(4027681)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.4
—
212.6
—
0
5
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
6.2
—
0
5
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
62
0.97
0.00
1.5
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.1
—
0
6
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_NOS_EXALLC – Melanoma in situ, other sites/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).